Search for Clinical Trial Results
AML With Myelodysplasia-related Features - 27 Studies Found
Status | Study |
Recruiting |
Study Name: Characterization of the Mechanisms of Resistance to Azacitidine Condition: Myelodysplastic Syndromes or Acute Myeloid Leukemia With Multilineage Dysplasia Date: 2010-09-27 |
Completed |
Study Name: Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Condition:
|
Recruiting |
Study Name: Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia Condition:
|
Recruiting |
Study Name: Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition:
|
Recruiting |
Study Name: Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
Interventions: |
Recruiting |
Study Name: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy Condition:
Interventions: Drug: eltrombopag olamine Given PO Other Names: |
Terminated |
Study Name: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
Interventions: |
Active, not recruiting |
Study Name: Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
Interventions: |